Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib with artemether/lumefantrine for uncomplicated falciparum malaria
PACTR202501900448720Phase 2Not yet recruiting
- Sponsor
- Purdue University
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of imatinib, artemether and lumefantrine in Malaria (7 arms), sponsored by Purdue University. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
03
Conditions
Malaria
Beyond the preview
Go deeper on PACTR202501900448720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202501900448720.